A note to the e-cigarette community
20 FEB
Editors Note: CRE is interested in the views of the e-cigarette community on the February 17 post Center for Regulatory Effectiveness (CRE) Provides FDA with Evidence Which Compels an Examination of the Health Effects of Counterfeit Cigarettes « A Public Participation Forum for the FDA Advisory Committee (TPSAC) which describes the extremely adverse health effects sustained from smoking counterfeit cigarettes.
It seems that the Center for Regulatory Effectiveness might have been duly impressed with the thoughtful responses on e-cigarette safety (How Safe Are E-Cigarettes? « A Public Participation Forum for the FDA Advisory Committee (TPSAC) ) and would like our input on the tobacco "black market".
Center for Regulatory Effectiveness (CRE) Provides FDA with Evidence Which Compels an Examination of the Health Effects of Counterfeit Cigarettes
17 FEB
Notwithstanding a law that directs the FDA tobacco Advisory Committee to review the health effects of counterfeit tobacco, the Tobacco Advisory Committee continues to ignore the law. In response to this dereliction of duty, the Center for Regulatory Effectiveness sent the following email to the FDA and its Advisory Committee.
It should be noted that when FDA regulates tobacco it is imperative that it not be able to pick and choose at will which studies are to be considered and those which are to be ignored; it must examine the totality of the record. It is difficult to understand why an agency charged with protecting public health would not want to examine the health effects of counterfeit cigarettes which are recognized throughout the world as having a demonstrable record of extremely adverse health impacts.